Penn Medicine Provider
Pathology and Laboratory Medicine
Leslie A. Litzky, MD
Accepting new patients
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP

About me

  • Director, Medical Pathology, Hospital of the University of Pennsylvania
  • Director, Surgical Pathology, Hospital of the University of Pennsylvania
  • Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: George Washington University
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: George Washington University Medical Center

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Litzky is a Penn Medicine physician.

Qualifications and experience

My research

Sterman DH, Alley E, Stevenson JP, Friedberg J, Metzger S, Recio A, Moon EK, Haas AR, Vachani A, Katz SI, Sun J, Heitjan D, Hwang WT, Litzky L, Yearley JH, Tan KS, Papasavvas E, Kennedy P, Montaner L, Cengel KA, Simone CB, Culligan M, Langer C, Albelda SM Pilot and feasibility trial of immuno-gene therapy of malignant mesothelioma using intrapleural delivery of adenovirus-interferon-alpha combined with chemotherapy , Clin Cancer Res, 22(15): 2016,3791-800


Kennedy GT, Okusanya OT, Keating JJ, Heitjan DD, Deshpande C, Litzky LA, Albelda SM, Drebin JA, Nie S, Low PS, Singhal S The optical biopsy: a novel technique for rapid intraoperative diagnosis of primary pulmonary adenocarcinomas , Ann Surg: 2015,602-9


Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson A, Roggli V, Travis WD, Wick M Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group , Arch Pathol Lab Med, 137(5): 2013,647-667


Zamani P, Kirkpatrick JN, Litzky LA, Verdino RJ Longevity of implantable devices explanted from patients having autopsy in hospitals , Am J Cardiol, 110(11): 2012,1643-1645


McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, Pare PD, Sin DD, Pierce RA, Woods JC, McWilliams AM, Mayo JR, Lam SC, Cooper JD, Hogg JC Small-airway obstruction and emphysema in chronic obstructive pulmonary disease , N Engl J Med, 365(17): 2011,1567-75


Litzky, LA Pulmonary neuroendocrine tumors , Surgical Pathology Clinics: 2010


Litzky LA Pulmonary sarcomatous tumors. , Arch Pathol Lab Med , 132: 2008,1104-1117


Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. , Mod Pathol, 18: 2005,105-110


Katzenstein A-LA, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM. Usual and non-specific interstitial pneumonia. Pathologic appraisal using biopsy and explant specimens. , Am J Surg Pathol, 12: 2002,1567-1577


Amin KM, Litzky LA, Smythe WR, Mooney AM, Morris JM, Mews DJY, Pass HI, Kari C, Rodeck U, Rauscher FJ, Kaiser LR, Albelda SM The Wilms' Tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma , Am J Pathol, 146: 1995,344-356